INTRODUCTION: Colon cancers diagnosed in the interval after a complete colonoscopy may occur due to limitations of colonoscopy or due to rapid tumor growth. The aim of this study was to compare the association of BRAF V600E mutation in interval versus non-interval colorectal cancers and to determine the relationship between BRAF mutation and 5-year survival. METHODS: We searched our institution's cancer registry for interval cancers, defined as colon cancers that developed within 5 years of a complete colonoscopy. These were frequency matched to patients with non-interval cancers. Archived cancer specimens were tested for BRAF V600E mutation and MSI. RESULTS: There were 63 interval and 131 non-interval cancers. BRAF mutation was present in 28% of interval cancers compared to 19% of non-interval cancers (P = 0.18). In a multivariable logistic regression model, proximal location (OR 1.85; 95% CI 1.01-3.8) and MSI (OR 2.7; 95% 1.1-6.8) were independently associated with interval cancers while BRAF mutation was not (OR 0.93; 95% CI 0.36-2.38). BRAF mutation portended a poor 5-year survival, particularly among microsatellite stable cancers. CONCLUSIONS: BRAF mutation is not associated with interval cancers but is a marker of poor prognosis, particularly in microsatellite stable cancers.
INTRODUCTION:Colon cancers diagnosed in the interval after a complete colonoscopy may occur due to limitations of colonoscopy or due to rapid tumor growth. The aim of this study was to compare the association of BRAFV600E mutation in interval versus non-interval colorectal cancers and to determine the relationship between BRAF mutation and 5-year survival. METHODS: We searched our institution's cancer registry for interval cancers, defined as colon cancers that developed within 5 years of a complete colonoscopy. These were frequency matched to patients with non-interval cancers. Archived cancer specimens were tested for BRAFV600E mutation and MSI. RESULTS: There were 63 interval and 131 non-interval cancers. BRAF mutation was present in 28% of interval cancers compared to 19% of non-interval cancers (P = 0.18). In a multivariable logistic regression model, proximal location (OR 1.85; 95% CI 1.01-3.8) and MSI (OR 2.7; 95% 1.1-6.8) were independently associated with interval cancers while BRAF mutation was not (OR 0.93; 95% CI 0.36-2.38). BRAF mutation portended a poor 5-year survival, particularly among microsatellite stable cancers. CONCLUSIONS:BRAF mutation is not associated with interval cancers but is a marker of poor prognosis, particularly in microsatellite stable cancers.
Authors: Shuji Ogino; Katsuhiko Nosho; Gregory J Kirkner; Takako Kawasaki; Jeffrey A Meyerhardt; Massimo Loda; Edward L Giovannucci; Charles S Fuchs Journal: Gut Date: 2008-10-02 Impact factor: 23.059
Authors: Shuji Ogino; Jeffrey A Meyerhardt; Takako Kawasaki; Jeffrey W Clark; David P Ryan; Matthew H Kulke; Peter C Enzinger; Brian M Wolpin; Massimo Loda; Charles S Fuchs Journal: Virchows Arch Date: 2007-03-20 Impact factor: 4.064
Authors: Wade S Samowitz; Carol Sweeney; Jennifer Herrick; Hans Albertsen; Theodore R Levin; Maureen A Murtaugh; Roger K Wolff; Martha L Slattery Journal: Cancer Res Date: 2005-07-15 Impact factor: 12.701
Authors: Mandeep S Sawhney; William D Farrar; Srivani Gudiseva; Douglas B Nelson; Frank A Lederle; Thomas S Rector; John H Bond Journal: Gastroenterology Date: 2006-12 Impact factor: 22.682
Authors: Joseph C Anderson; Koorosh Moezardalan; Catherine R Messina; Michael Latreille; Robert D Shaw Journal: Dig Dis Sci Date: 2011-07-13 Impact factor: 3.199
Authors: Timothy J Price; Carol Beeke; Amanda Rose Townsend; Louisa Lo; Roy Amitesh; Robert Padbury; David Roder; Guy Maddern; James Moore; Christos Karapetis Journal: Mol Diagn Ther Date: 2016-02 Impact factor: 4.074
Authors: Amanda I Phipps; Noralane M Lindor; Mark A Jenkins; John A Baron; Aung Ko Win; Steven Gallinger; Robert Gryfe; Polly A Newcomb Journal: Dis Colon Rectum Date: 2013-08 Impact factor: 4.585
Authors: Elena M Stoffel; Rune Erichsen; Trine Frøslev; Lars Pedersen; Mogens Vyberg; Erika Koeppe; Seth D Crockett; Stanley R Hamilton; Henrik T Sørensen; John A Baron Journal: Gastroenterology Date: 2016-07-19 Impact factor: 22.682
Authors: James M Richter; Maria Simona Pino; Thomas R Austin; Emily Campbell; Jackie Szymonifka; Andrea L Russo; Theodore S Hong; Darrell Borger; A John Iafrate; Daniel C Chung Journal: Dig Dis Sci Date: 2014-04-05 Impact factor: 3.199